Clinical Trial Update: A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase II neoadjuvant trial evaluating the PD-1 vaccine PD1-Vaxx in operable MSI-high colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• PD1-Vaxx

Snippet

Sponsor: University of Southampton | Conditions: Colorectal Cancer | Phase 2 | Status: RECRUITING